AAAAAA

   
Results: 1-7 |
Results: 7

Authors: Chiaramonte, MG Cheever, AW Malley, JD Donaldson, DD Wynn, TA
Citation: Mg. Chiaramonte et al., Studies of murine schistosomiasis reveal interleukin-13 blockade as a treatment for established and progressive liver fibrosis, HEPATOLOGY, 34(2), 2001, pp. 273-282

Authors: Vaillant, B Chiaramonte, MG Cheever, AW Soloway, PD Wynn, TA
Citation: B. Vaillant et al., Regulation of hepatic fibrosis and extracellular matrix genes by the Th response: New insight into the role of tissue inhibitors of matrix metalloproteinases, J IMMUNOL, 167(12), 2001, pp. 7017-7026

Authors: Chiaramonte, MG Hesse, M Cheever, AW Wynn, TA
Citation: Mg. Chiaramonte et al., CpG oligonucleotides can prophylactically immunize against Th2-mediated schistosome egg-induced pathology by an IL-12-independent mechanism, J IMMUNOL, 164(2), 2000, pp. 973-985

Authors: Chiaramonte, MG Schopf, LR Neben, TY Cheever, AW Donaldson, DD Wynn, TA
Citation: Mg. Chiaramonte et al., IL-13 is a key regulatory cytokine for Th2 cell-mediated pulmonary granuloma formation and IgE responses induced by Schistosoma mansoni eggs, J IMMUNOL, 162(2), 1999, pp. 920-930

Authors: Chiaramonte, MG Donaldson, DD Cheever, AW Wynn, TA
Citation: Mg. Chiaramonte et al., An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response, J CLIN INV, 104(6), 1999, pp. 777-785

Authors: Chiaramonte, MG Frank, FM Furer, GM Taranto, NJ Margni, RA Malchiodi, EL
Citation: Mg. Chiaramonte et al., Polymerase chain reaction reveals Trypanosoma cruzi infection suspected byserology in cutaneous and mucocutaneous leishmaniasis patients, ACT TROP, 72(3), 1999, pp. 295-308

Authors: Kaplan, D Baldi, C Chiaramonte, MG Fernandez, MM Levin, MJ Malchiodi, E Baldi, A
Citation: D. Kaplan et al., Expression of a recombinant Fab antibody fragment against cruzipain, the major cysteine proteinase of Trypanosoma cruzi, BIOC BIOP R, 253(1), 1998, pp. 53-58
Risultati: 1-7 |